These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
660 related items for PubMed ID: 16387547
1. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients. Jacobson MA, Sinclair E, Bredt B, Agrillo L, Black D, Epling CL, Carvidi A, Ho T, Bains R, Adler SP. J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547 [Abstract] [Full Text] [Related]
5. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype. Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group. J Infect Dis; 2006 Dec 01; 194(11):1537-46. PubMed ID: 17083038 [Abstract] [Full Text] [Related]
6. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells. Melenhorst JJ, Solomon SR, Shenoy A, Hensel NF, McCoy JP, Keyvanfar K, Barrett AJ. J Immunother; 2006 Dec 01; 29(4):436-43; discussion 365-6. PubMed ID: 16799339 [Abstract] [Full Text] [Related]
7. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation. Paine A, Oelke M, Tischer S, Heuft HG, Blasczyk R, Eiz-Vesper B. J Immunother; 2010 Jan 01; 33(1):60-72. PubMed ID: 19952955 [Abstract] [Full Text] [Related]
8. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients. Tormo N, Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, López-Aldeguer N, Hernández-Boluda JC, Remigia MJ, Garcia-Noblejas A, Gimeno C, Navarro D. Bone Marrow Transplant; 2010 Mar 01; 45(3):543-9. PubMed ID: 19617905 [Abstract] [Full Text] [Related]
9. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection. Wang Z, La Rosa C, Lacey SF, Maas R, Mekhoubad S, Britt WJ, Diamond DJ. J Clin Virol; 2006 Mar 01; 35(3):324-31. PubMed ID: 16388983 [Abstract] [Full Text] [Related]
10. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. Komanduri KV, Donahoe SM, Moretto WJ, Schmidt DK, Gillespie G, Ogg GS, Roederer M, Nixon DF, McCune JM. Virology; 2001 Jan 20; 279(2):459-70. PubMed ID: 11162802 [Abstract] [Full Text] [Related]
11. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host. Lilleri D, Zelini P, Fornara C, Comolli G, Revello MG, Gerna G. Clin Immunol; 2009 Jun 20; 131(3):395-403. PubMed ID: 19268633 [Abstract] [Full Text] [Related]
12. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. Kern F, Bunde T, Faulhaber N, Kiecker F, Khatamzas E, Rudawski IM, Pruss A, Gratama JW, Volkmer-Engert R, Ewert R, Reinke P, Volk HD, Picker LJ. J Infect Dis; 2002 Jun 15; 185(12):1709-16. PubMed ID: 12085315 [Abstract] [Full Text] [Related]
16. Rapid generation of CMV pp65-specific T cells for immunotherapy. Bao L, Sun Q, Lucas KG. J Immunother; 2007 Jun 15; 30(5):557-61. PubMed ID: 17589296 [Abstract] [Full Text] [Related]
18. Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity. Na IK, Letsch A, Guerreiro M, Bauer S, Noack I, Geginat J, Reinke P, Loesch M, Kienapfel H, Thiel E, Volk HD, Scheibenbogen C. J Immunother; 2009 Jun 15; 32(9):907-13. PubMed ID: 19816191 [Abstract] [Full Text] [Related]